๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Double-Blind, Placebo-Controlled Study of Single-Dose Amphetamine Formulations in ADHD

โœ Scribed by JAMES, REGINA S.; SHARP, WENDY S.; BASTAIN, THERESA M.; LEE, PATTI P.; WALTER, JAMES M.; CZARNOLEWSKI, MARK; CASTELLANOS, F. XAVIER

Book ID
125442217
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
150 KB
Volume
40
Category
Article
ISSN
1527-5418

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Placebo-controlled, double-blind dose-fi
Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating parkinsonian patients
โœ Yoshikuni Mizuno; Ichiro Kanazawa; Sadako Kuno; Nobuo Yanagisawa; Mitsutoshi Yam ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 63 KB ๐Ÿ‘ 1 views

## Abstract We conducted a multicenter randomized, placeboโ€controlled doubleโ€blind parallelโ€group study in Japanese Parkinson's disease (PD) patients with wearingโ€off motor fluctuations to determine the clinical efficacy and safety of entacapone as an adjunct to concomitant treatment with levodopa

A double-blind, placebo-controlled singl
A double-blind, placebo-controlled single dose trial of intravenous flumazenil in Alzheimer's disease
โœ Lisa Templeton; Andrew Barker; Keith Wesnes; David Wilkinson ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 203 KB ๐Ÿ‘ 2 views

Benzodiazepine agonists have been shown to reduce cognitive functioning by producing attentional deยฎcits similar to those produced by muscarinic antagonists. It has therefore been postulated that benzodiazepine antagonists may improve cognitive function in patients with Alzheimer's disease by indire